Last updated: 18 July 2024 at 7:09pm EST

Jeffrey Jerome Ludwig Net Worth




The estimated Net Worth of Jeffrey Jerome Ludwig is at least $5.09 Million dollars as of 17 July 2024. Mr Ludwig owns over 2,598 units of Puma Biotechnology Inc stock worth over $295,970 and over the last 5 years he sold PBYI stock worth over $185,559. In addition, he makes $4,609,635 as Chief Commercial Officer at Puma Biotechnology Inc.

Mr Ludwig PBYI stock SEC Form 4 insiders trading

Mr has made over 7 trades of the Puma Biotechnology Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 2,598 units of PBYI stock worth $9,613 on 17 July 2024.

The largest trade he's ever made was selling 12,956 units of Puma Biotechnology Inc stock on 3 January 2024 worth over $58,172. On average, Mr trades about 4,237 units every 77 days since 2020. As of 17 July 2024 he still owns at least 118,388 units of Puma Biotechnology Inc stock.

You can see the complete history of Mr Ludwig stock trades at the bottom of the page.





Mr. Jeffrey Jerome Ludwig biography

Jeffrey Jerome Ludwig is the Chief Commercial Officer at Puma Biotechnology Inc.

What is the salary of Mr Ludwig?

As the Chief Commercial Officer of Puma Biotechnology Inc, the total compensation of Mr Ludwig at Puma Biotechnology Inc is $4,609,635. There are 1 executives at Puma Biotechnology Inc getting paid more, with Alan H. Auerbach having the highest compensation of $5,693,423.



How old is Mr Ludwig?

Mr Ludwig is 55, he's been the Chief Commercial Officer of Puma Biotechnology Inc since . There are 8 older and 5 younger executives at Puma Biotechnology Inc. The oldest executive at Puma Biotechnology Inc is Jay Moyes, 66, who is the Lead Independent Director.

What's Mr Ludwig's mailing address?

Jeffrey's mailing address filed with the SEC is C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BLVD., SUITE 2150, LOS ANGELES, CA, 90024.

Insiders trading at Puma Biotechnology Inc

Over the last 13 years, insiders at Puma Biotechnology Inc have traded over $168,440,369 worth of Puma Biotechnology Inc stock and bought 2,655,298 units worth $48,866,148 . The most active insiders traders include Capital Partners Gp, L.L.C...., Steven Lo, and Troy Edward Wilson. On average, Puma Biotechnology Inc executives and independent directors trade stock every 18 days with the average trade being worth of $60,225. The most recent stock trade was executed by Michael Patrick Miller on 12 August 2024, trading 23,358 units of PBYI stock currently worth $81,519.



What does Puma Biotechnology Inc do?

we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.



What does Puma Biotechnology Inc's logo look like?

Puma Biotechnology Inc logo

Complete history of Mr Ludwig stock trades at Puma Biotechnology Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
17 Jul 2024 Jeffrey Jerome Ludwig
Chief Commercial Officer
Sale 2,598 $3.70 $9,613
17 Jul 2024
118,388
2 Jul 2024 Jeffrey Jerome Ludwig
Chief Commercial Officer
Sale 6,051 $3.27 $19,787
2 Jul 2024
120,986
3 Jan 2024 Jeffrey Jerome Ludwig
Chief Commercial Officer
Sale 12,956 $4.49 $58,172
3 Jan 2024
99,970
3 Jul 2023 Jeffrey Jerome Ludwig
Chief Commercial Officer
Sale 12,103 $3.31 $40,061
3 Jul 2023
112,926
3 Jan 2023 Jeffrey Jerome Ludwig
Chief Commercial Officer
Sale 6,568 $4.18 $27,454
3 Jan 2023
58,057
5 Jul 2022 Jeffrey Jerome Ludwig
Chief Commercial Officer
Sale 5,835 $2.63 $15,346
5 Jul 2022
64,625
3 Jan 2022 Jeffrey Jerome Ludwig
Chief Commercial Officer
Sale 4,727 $3.20 $15,126
3 Jan 2022
31,342


Puma Biotechnology Inc executives and stock owners

Puma Biotechnology Inc executives and other stock owners filed with the SEC include: